Project MEDI 9929 in Adult Subjects with Moderate-to-Severe Atopic Dermatitis

Basic data

Title:
MEDI 9929 in Adult Subjects with Moderate-to-Severe Atopic Dermatitis
Duration:
30/09/2015 to 29/02/2016
Abstract / short description:
A Phase 2a Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects with Moderate-to-Severe Atopic Dermatitis
Keywords:
atopic dermatitis
Atopische Dermatitis
antibodies
Antikörper

Involved staff

Managers

Faculty of Medicine
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Cambridge, United Kingdom
Help

will be deleted permanently. This cannot be undone.